Header Logo

Connection

THOMAS KOSTEN to Adult

Back to Details
This is a "connection" page, showing publications THOMAS KOSTEN has written about Adult.
THOMAS KOSTEN
Connection Strength
2.740
Adult
  1. Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo-controlled crossover laboratory study. Am J Addict. 2025 Jan; 34(1):7-14.
    View in: PubMed
    Score: 0.051
  2. Ginkgo biloba for Tardive Dyskinesia and Plasma MnSOD Activity: Association with MnSOD Ala-9Val Variant: A Randomized, Double-blind Trial. Curr Neuropharmacol. 2024; 22(14):2443-2452.
    View in: PubMed
    Score: 0.049
  3. Hospital Stay in Synthetic Cannabinoid Users With Bipolar Disorder, Schizophrenia, or Other Psychotic Disorders Compared With Cannabis Users. J Stud Alcohol Drugs. 2019 03; 80(2):230-235.
    View in: PubMed
    Score: 0.035
  4. Opioid Use Disorder After Self-medicating Pain From Traumatic Brain Injury. JAMA Psychiatry. 2018 06 01; 75(6):649-650.
    View in: PubMed
    Score: 0.033
  5. Pharmacologic management of comorbid post-traumatic stress disorder and addictions. Am J Addict. 2015 Dec; 24(8):705-12.
    View in: PubMed
    Score: 0.028
  6. Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans. Psychiatry Res. 2015 Nov 30; 230(1):44-9.
    View in: PubMed
    Score: 0.027
  7. Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial. Drug Alcohol Depend. 2014 Jul 01; 140:42-7.
    View in: PubMed
    Score: 0.025
  8. Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment. Drug Alcohol Depend. 2014 Mar 01; 136:36-42.
    View in: PubMed
    Score: 0.024
  9. The ?-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial. Psychiatr Genet. 2013 Dec; 23(6):225-32.
    View in: PubMed
    Score: 0.024
  10. Socio-demographic and clinical characteristics of heavy and non-heavy smokers among schizophrenia inpatients in a Chinese Han population. Psychopharmacology (Berl). 2014 Jan; 231(1):305-14.
    View in: PubMed
    Score: 0.024
  11. Prevalence, demographic and clinical correlates of suicide attempts in Chinese medicated chronic inpatients with schizophrenia. J Psychiatr Res. 2013 Oct; 47(10):1370-5.
    View in: PubMed
    Score: 0.023
  12. Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia. Drug Alcohol Depend. 2013 Oct 01; 132(3):674-80.
    View in: PubMed
    Score: 0.023
  13. Clinical symptoms and cognitive impairment associated with male schizophrenia relate to plasma manganese superoxide dismutase activity: a case-control study. J Psychiatr Res. 2013 Aug; 47(8):1049-53.
    View in: PubMed
    Score: 0.023
  14. Cognitive function, plasma MnSOD activity, and MnSOD Ala-9Val polymorphism in patients with schizophrenia and normal controls. Schizophr Bull. 2014 May; 40(3):592-601.
    View in: PubMed
    Score: 0.023
  15. Interleukin 18 and cognitive impairment in first episode and drug na?ve schizophrenia versus healthy controls. Brain Behav Immun. 2013 Aug; 32:105-11.
    View in: PubMed
    Score: 0.023
  16. DBH gene as predictor of response in a cocaine vaccine clinical trial. Neurosci Lett. 2013 Apr 29; 541:29-33.
    View in: PubMed
    Score: 0.023
  17. BDNF Val66Met variant and smoking in a Chinese population. PLoS One. 2012; 7(12):e53295.
    View in: PubMed
    Score: 0.023
  18. Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls. Schizophr Res. 2013 Feb; 143(2-3):301-6.
    View in: PubMed
    Score: 0.023
  19. Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia. Am J Psychiatry. 2012 Sep; 169(9):974-81.
    View in: PubMed
    Score: 0.022
  20. Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine ?-hydroxylase. Biol Psychiatry. 2013 Feb 01; 73(3):219-24.
    View in: PubMed
    Score: 0.022
  21. Association of functional dopamine-beta-hydroxylase (DBH) 19 bp insertion/deletion polymorphism with smoking severity in male schizophrenic smokers. Schizophr Res. 2012 Oct; 141(1):48-53.
    View in: PubMed
    Score: 0.022
  22. Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients. J Clin Psychiatry. 2012 Jul; 73(7):1025-33.
    View in: PubMed
    Score: 0.022
  23. Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba. Biol Psychiatry. 2012 Oct 15; 72(8):700-6.
    View in: PubMed
    Score: 0.022
  24. Cigarette smoking and cognitive function in Chinese male schizophrenia: a case-control study. PLoS One. 2012; 7(5):e36563.
    View in: PubMed
    Score: 0.022
  25. Plasma total antioxidant status and cognitive impairments in schizophrenia. Schizophr Res. 2012 Aug; 139(1-3):66-72.
    View in: PubMed
    Score: 0.022
  26. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls. Hum Genet. 2012 Jul; 131(7):1187-95.
    View in: PubMed
    Score: 0.021
  27. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia. Psychopharmacology (Berl). 2012 Jul; 222(2):277-84.
    View in: PubMed
    Score: 0.021
  28. Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia. Neuropharmacology. 2012 Apr; 62(5-6):1928-34.
    View in: PubMed
    Score: 0.021
  29. Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms. Addiction. 2012 Jan; 107(1):131-41.
    View in: PubMed
    Score: 0.021
  30. Smoking and tardive dyskinesia in male patients with chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15; 35(7):1765-9.
    View in: PubMed
    Score: 0.020
  31. Smoking initiation and schizophrenia: a replication study in a Chinese Han population. Schizophr Res. 2010 Jun; 119(1-3):110-4.
    View in: PubMed
    Score: 0.019
  32. Sex difference in the prevalence of smoking in Chinese schizophrenia. J Psychiatr Res. 2010 Oct; 44(14):986-8.
    View in: PubMed
    Score: 0.019
  33. Increased S100B serum levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements. J Psychiatr Res. 2010 May; 44(7):429-33.
    View in: PubMed
    Score: 0.018
  34. Drug users' adherence to a 6-month vaccination protocol: effects of motivational incentives. Drug Alcohol Depend. 2010 Feb 01; 107(1):76-9.
    View in: PubMed
    Score: 0.018
  35. Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial. Arch Gen Psychiatry. 2009 Oct; 66(10):1116-23.
    View in: PubMed
    Score: 0.018
  36. The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients. Schizophr Res. 2009 Sep; 113(2-3):151-7.
    View in: PubMed
    Score: 0.018
  37. Gender differences in the prevalence, risk and clinical correlates of tardive dyskinesia in Chinese schizophrenia. Psychopharmacology (Berl). 2009 Sep; 205(4):647-54.
    View in: PubMed
    Score: 0.018
  38. Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics. Psychopharmacology (Berl). 2009 May; 204(1):177-84.
    View in: PubMed
    Score: 0.017
  39. Atomoxetine attenuates dextroamphetamine effects in humans. Am J Drug Alcohol Abuse. 2009; 35(6):412-6.
    View in: PubMed
    Score: 0.017
  40. Progesterone effects on cocaine use in male cocaine users maintained on methadone: a randomized, double-blind, pilot study. Exp Clin Psychopharmacol. 2007 Oct; 15(5):453-60.
    View in: PubMed
    Score: 0.016
  41. Brain-derived neurotrophic factor polymorphisms and smoking in schizophrenia. Schizophr Res. 2007 Dec; 97(1-3):299-301.
    View in: PubMed
    Score: 0.016
  42. Lack of association between the BDNF C270T polymorphism and schizophrenia in a Chinese Han population. Schizophr Res. 2007 Dec; 97(1-3):297-8.
    View in: PubMed
    Score: 0.016
  43. Disrupted antioxidant enzyme activity and elevated lipid peroxidation products in schizophrenic patients with tardive dyskinesia. J Clin Psychiatry. 2007 May; 68(5):754-60.
    View in: PubMed
    Score: 0.015
  44. Nicotine dependence, symptoms and oxidative stress in male patients with schizophrenia. Neuropsychopharmacology. 2007 Sep; 32(9):2020-4.
    View in: PubMed
    Score: 0.015
  45. Performance of cocaine dependent individuals and controls on a response inhibition task with varying levels of difficulty. Am J Drug Alcohol Abuse. 2007; 33(5):717-26.
    View in: PubMed
    Score: 0.015
  46. Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings. Psychopharmacology (Berl). 2007 Mar; 190(4):569-74.
    View in: PubMed
    Score: 0.015
  47. Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology. 2006 Mar; 31(3):644-50.
    View in: PubMed
    Score: 0.014
  48. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Arch Gen Psychiatry. 2006 Feb; 63(2):219-28.
    View in: PubMed
    Score: 0.014
  49. Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers. Psychopharmacology (Berl). 2006 Mar; 184(3-4):645-51.
    View in: PubMed
    Score: 0.014
  50. Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers. Psychopharmacology (Berl). 2005 Sep; 181(3):504-10.
    View in: PubMed
    Score: 0.014
  51. Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients. Drug Alcohol Depend. 2005 Aug 01; 79(2):157-65.
    View in: PubMed
    Score: 0.014
  52. Vaccine pharmacotherapy for the treatment of cocaine dependence. Biol Psychiatry. 2005 Jul 15; 58(2):158-64.
    View in: PubMed
    Score: 0.014
  53. The association between cannabis use and suicidal intensity in psychiatric inpatients. Am J Addict. 2025 Sep; 34(5):506-516.
    View in: PubMed
    Score: 0.013
  54. Cortical excitability in cocaine-dependent patients: a replication and extension of TMS findings. J Psychiatr Res. 2005 May; 39(3):295-302.
    View in: PubMed
    Score: 0.013
  55. Nitrate ameliorates alcohol-induced cognitive impairment via oral microbiota. J Neuroinflammation. 2025 Apr 15; 22(1):106.
    View in: PubMed
    Score: 0.013
  56. The effect of alcohol on the neuropsychological functioning of recently abstinent cocaine-dependent subjects. Am J Addict. 2005 Mar-Apr; 14(2):166-78.
    View in: PubMed
    Score: 0.013
  57. Long-Term Safety and Efficacy of Esmethadone in Patients With Major Depressive Disorder: Findings From a 12-Month Open-Label Study. J Clin Psychiatry. 2025 Feb 17; 86(1).
    View in: PubMed
    Score: 0.013
  58. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. Am J Psychiatry. 2005 Feb; 162(2):340-9.
    View in: PubMed
    Score: 0.013
  59. Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response. Am J Addict. 2005 Jan-Feb; 14(1):8-17.
    View in: PubMed
    Score: 0.013
  60. Use of Cigarettes and E-Cigarettes, Impulsivity, and Anxiety: Influences on Suicidal Ideation Among Youth and Young Adults in Texas. Nicotine Tob Res. 2024 12 23; 27(1):54-60.
    View in: PubMed
    Score: 0.013
  61. New medication strategies for comorbid substance use and bipolar affective disorders. Biol Psychiatry. 2004 Nov 15; 56(10):771-7.
    View in: PubMed
    Score: 0.013
  62. Transcranial Direct Current Stimulation Combined With Repetitive Transcranial Magnetic Stimulation for Depression: A Randomized Clinical Trial. JAMA Netw Open. 2024 11 04; 7(11):e2444306.
    View in: PubMed
    Score: 0.013
  63. Effects of progesterone treatment on cocaine responses in male and female cocaine users. Pharmacol Biochem Behav. 2004 Aug; 78(4):699-705.
    View in: PubMed
    Score: 0.013
  64. Cognitive enhancing effect of rTMS combined with tDCS in patients with major depressive disorder: a double-blind, randomized, sham-controlled study. BMC Med. 2024 06 20; 22(1):253.
    View in: PubMed
    Score: 0.013
  65. Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants: A Phase 3 Randomized Controlled Trial. J Clin Psychiatry. 2024 Jun 17; 85(3).
    View in: PubMed
    Score: 0.013
  66. Enhancing post-traumatic stress disorder patient assessment: leveraging natural language processing for research of domain criteria identification using electronic medical records. BMC Med Inform Decis Mak. 2024 Jun 04; 24(1):154.
    View in: PubMed
    Score: 0.013
  67. Gender-specific vulnerability for rCBF abnormalities among cocaine abusers. Neuroreport. 2004 Apr 09; 15(5):797-801.
    View in: PubMed
    Score: 0.012
  68. Correlates of suicidal behaviors and genetic risk among United States veterans with schizophrenia or bipolar I disorder. Mol Psychiatry. 2024 Aug; 29(8):2399-2407.
    View in: PubMed
    Score: 0.012
  69. Platelet abnormalities associated with cerebral perfusion defects in cocaine dependence. Biol Psychiatry. 2004 Jan 01; 55(1):91-7.
    View in: PubMed
    Score: 0.012
  70. Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Addiction. 2003 Nov; 98(11):1625-32.
    View in: PubMed
    Score: 0.012
  71. Aspirin or amiloride for cerebral perfusion defects in cocaine dependence. Drug Alcohol Depend. 2003 Aug 20; 71(2):187-94.
    View in: PubMed
    Score: 0.012
  72. D-cycloserine-Naloxone interactions in opioid-dependent humans under a novel-response naloxone discrimination procedure. Exp Clin Psychopharmacol. 2003 Aug; 11(3):237-46.
    View in: PubMed
    Score: 0.012
  73. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management. Am J Drug Alcohol Abuse. 2003 Aug; 29(3):497-514.
    View in: PubMed
    Score: 0.012
  74. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence. Am J Drug Alcohol Abuse. 2003; 29(4):713-27.
    View in: PubMed
    Score: 0.011
  75. Cerebral perfusion defects in combined cocaine and alcohol dependence. Drug Alcohol Depend. 2002 Sep 01; 68(1):95-104.
    View in: PubMed
    Score: 0.011
  76. A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol Psychiatry. 2002 Jul 01; 52(1):53-61.
    View in: PubMed
    Score: 0.011
  77. Sensory gating and psychosis vulnerability in cocaine-dependent individuals: preliminary data. Biol Psychiatry. 2002 Apr 15; 51(8):683-6.
    View in: PubMed
    Score: 0.011
  78. Human therapeutic cocaine vaccine: safety and immunogenicity. Vaccine. 2002 Jan 15; 20(7-8):1196-204.
    View in: PubMed
    Score: 0.011
  79. Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers. Am J Addict. 2002; 11(2):111-23.
    View in: PubMed
    Score: 0.011
  80. Isradipine enhancement of cerebral blood flow in abstinent cocaine abusers with and without chronic perfusion deficits. Am J Addict. 2002; 11(3):200-8.
    View in: PubMed
    Score: 0.011
  81. Long-Term Impact of COVID-19 on Mental Health among the General Public: A Nationwide Longitudinal Study in China. Int J Environ Res Public Health. 2021 08 20; 18(16).
    View in: PubMed
    Score: 0.010
  82. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am J Psychiatry. 2001 Aug; 158(8):1184-90.
    View in: PubMed
    Score: 0.010
  83. Office-based treatment for opioid dependence: reaching new patient populations. Am J Psychiatry. 2001 Aug; 158(8):1200-4.
    View in: PubMed
    Score: 0.010
  84. Effects of cocaine prior to and during bupropion maintenance in cocaine-abusing volunteers. Drug Alcohol Depend. 2001 Jul 01; 63(2):155-67.
    View in: PubMed
    Score: 0.010
  85. The OPRD1 rs678849 variant influences outcome of disulfiram treatment for cocaine dependency in methadone-maintained patients. Psychiatr Genet. 2021 06 01; 31(3):88-94.
    View in: PubMed
    Score: 0.010
  86. A randomized trial of safety and pharmacodynamic interactions between a selective glucocorticoid receptor antagonist, PT150, and ethanol in healthy volunteers. Sci Rep. 2021 05 10; 11(1):9876.
    View in: PubMed
    Score: 0.010
  87. Contingency management interventions: from research to practice. Am J Psychiatry. 2001 May; 158(5):694-702.
    View in: PubMed
    Score: 0.010
  88. Internet Addiction Increases in the General Population During COVID-19: Evidence From China. Am J Addict. 2021 07; 30(4):389-397.
    View in: PubMed
    Score: 0.010
  89. Genome-Wide Association Studies of Schizophrenia and Bipolar Disorder in a Diverse Cohort of US Veterans. Schizophr Bull. 2021 03 16; 47(2):517-529.
    View in: PubMed
    Score: 0.010
  90. Association of Symptoms of Attention Deficit and Hyperactivity with Problematic Internet Use among University Students in Wuhan, China During the COVID-19 Pandemic. J Affect Disord. 2021 05 01; 286:220-227.
    View in: PubMed
    Score: 0.010
  91. Quantitative medial temporal lobe brain morphology and hypothalamic-pituitary-adrenal axis function in cocaine dependence: a preliminary report. Drug Alcohol Depend. 2001 Mar 01; 62(1):49-56.
    View in: PubMed
    Score: 0.010
  92. Cognitive Deficits and Clinical Symptoms with Hippocampal Subfields in First-Episode and Never-Treated Patients with Schizophrenia. Cereb Cortex. 2021 01 01; 31(1):89-96.
    View in: PubMed
    Score: 0.010
  93. Cingulate Cortex Structural Alterations in Substance Use Disorder Psychiatric Inpatients. Am J Addict. 2021 01; 30(1):72-79.
    View in: PubMed
    Score: 0.010
  94. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry. 2000 Nov; 157(11):1835-42.
    View in: PubMed
    Score: 0.010
  95. A randomized controlled trial of auricular acupuncture for cocaine dependence. Arch Intern Med. 2000 Aug 14-28; 160(15):2305-12.
    View in: PubMed
    Score: 0.010
  96. Thrice-weekly versus daily buprenorphine maintenance. Biol Psychiatry. 2000 Jun 15; 47(12):1072-9.
    View in: PubMed
    Score: 0.010
  97. Brief Report: Increased Addictive Internet and Substance Use Behavior During the COVID-19 Pandemic in China. Am J Addict. 2020 07; 29(4):268-270.
    View in: PubMed
    Score: 0.010
  98. Significant interaction between clozapine and cocaine in cocaine addicts. Drug Alcohol Depend. 2000 May 01; 59(2):153-63.
    View in: PubMed
    Score: 0.009
  99. Altered habenula resting state functional connectivity in deprived veteran tobacco smokers: A pilot study. Bull Menninger Clin. 2020; 84(1):21-34.
    View in: PubMed
    Score: 0.009
  100. Doxazosin treatment in cocaine use disorder: pharmacogenetic response based on an alpha-1 adrenoreceptor subtype D genetic variant. Am J Drug Alcohol Abuse. 2020; 46(2):184-193.
    View in: PubMed
    Score: 0.009
  101. Use of Guanfacine for Cannabis Use Disorder and Related Symptomology. Am J Addict. 2019 11; 28(6):455-464.
    View in: PubMed
    Score: 0.009
  102. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone. Arch Gen Psychiatry. 1999 Sep; 56(9):812-20.
    View in: PubMed
    Score: 0.009
  103. Lofexidine in Combination With Oral Naltrexone for Opioid Use Disorder Relapse Prevention: A Pilot Randomized, Double-Blind, Placebo-Controlled Study. Am J Addict. 2019 11; 28(6):480-488.
    View in: PubMed
    Score: 0.009
  104. The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia. Schizophr Res. 2019 10; 212:92-98.
    View in: PubMed
    Score: 0.009
  105. Insular resting state functional connectivity is associated with gut microbiota diversity. Eur J Neurosci. 2019 08; 50(3):2446-2452.
    View in: PubMed
    Score: 0.009
  106. Pharmacogenetic role of dopamine transporter (SLC6A3) variation on response to disulfiram treatment for cocaine addiction. Am J Addict. 2019 07; 28(4):311-317.
    View in: PubMed
    Score: 0.009
  107. Buprenorphine for the treatment of posttraumatic stress disorder. Am J Addict. 2019 02; 28(2):86-91.
    View in: PubMed
    Score: 0.009
  108. Interactions of cocaine with nimodipine: a brief report. Am J Addict. 1999; 8(1):77-81.
    View in: PubMed
    Score: 0.009
  109. The effect of lamotrigine on naloxone-precipitated opiate withdrawal. Drug Alcohol Depend. 1998 Oct 01; 52(2):173-6.
    View in: PubMed
    Score: 0.008
  110. FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration. Am J Addict. 2018 10; 27(7):567-573.
    View in: PubMed
    Score: 0.008
  111. Hydromorphone-naloxone combinations in opioid-dependent humans under a naloxone novel-response discrimination procedure. Exp Clin Psychopharmacol. 1998 May; 6(2):169-78.
    View in: PubMed
    Score: 0.008
  112. A comprehensive pharmacologic-psychosocial treatment program for HIV-seropositive cocaine- and opioid-dependent patients. Preliminary findings. J Subst Abuse Treat. 1998 May-Jun; 15(3):261-5.
    View in: PubMed
    Score: 0.008
  113. Regional cerebral blood flow during acute and chronic abstinence from combined cocaine-alcohol abuse. Drug Alcohol Depend. 1998 May 01; 50(3):187-95.
    View in: PubMed
    Score: 0.008
  114. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure. Behav Pharmacol. 1998 May; 9(3):207-17.
    View in: PubMed
    Score: 0.008
  115. Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: Association with pro-inflammatory cytokine levels. Prog Neuropsychopharmacol Biol Psychiatry. 2018 07 13; 85:69-76.
    View in: PubMed
    Score: 0.008
  116. Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial. Drug Alcohol Depend. 2018 06 01; 187:171-178.
    View in: PubMed
    Score: 0.008
  117. Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal. Biol Psychiatry. 1998 Feb 15; 43(4):278-81.
    View in: PubMed
    Score: 0.008
  118. A preliminary investigation of lamotrigine for cocaine abuse in HIV-seropositive patients. Am J Drug Alcohol Abuse. 1998 Feb; 24(1):85-101.
    View in: PubMed
    Score: 0.008
  119. Exenatide once weekly for smoking cessation: study protocol for a randomized clinical trial. Medicine (Baltimore). 2018 Jan; 97(2):e9567.
    View in: PubMed
    Score: 0.008
  120. Prognostic factors in Buprenorphine- versus methadone-maintained patients. J Nerv Ment Dis. 1998 Jan; 186(1):35-43.
    View in: PubMed
    Score: 0.008
  121. Effect of LAAM dose on opiate use in opioid-dependent patients. A pilot study. Am J Addict. 1998; 7(4):272-82.
    View in: PubMed
    Score: 0.008
  122. Moderators of response to sertraline versus placebo among recently abstinent, cocaine dependent patients: A retrospective analysis of two clinical trials. Am J Addict. 2017 Dec; 26(8):807-814.
    View in: PubMed
    Score: 0.008
  123. Treatment of early AIDS dementia in intravenous drug users: high versus low dose peptide T. Am J Drug Alcohol Abuse. 1997 Nov; 23(4):543-53.
    View in: PubMed
    Score: 0.008
  124. Altered anterior cingulate cortex to hippocampus effective connectivity in response to drug cues in men with cocaine use disorder. Psychiatry Res Neuroimaging. 2018 01 30; 271:59-66.
    View in: PubMed
    Score: 0.008
  125. Association between self-report of cognitive impairment, HIV status, and cocaine use in a sample of cocaine-dependent methadone-maintained patients. Addict Behav. 1997 Sep-Oct; 22(5):599-611.
    View in: PubMed
    Score: 0.008
  126. Increased habenular connectivity in opioid users is associated with an a5 subunit nicotinic receptor genetic variant. Am J Addict. 2017 Oct; 26(7):751-759.
    View in: PubMed
    Score: 0.008
  127. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry. 1997 Aug; 54(8):713-20.
    View in: PubMed
    Score: 0.008
  128. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study. J Neuropsychiatry Clin Neurosci. 2018; 30(1):66-76.
    View in: PubMed
    Score: 0.008
  129. Dose dependent effects of yohimbine on methadone maintained patients. Am J Drug Alcohol Abuse. 1997 May; 23(2):327-33.
    View in: PubMed
    Score: 0.008
  130. Psychopathology and personality traits associated with driving while intoxicated in Beijing, China: Implications for interventions. Am J Addict. 2017 Jun; 26(4):374-378.
    View in: PubMed
    Score: 0.008
  131. Effects of gamma-hydroxybutyric acid (GHB) in opioid-dependent patients. J Subst Abuse Treat. 1997 Mar-Apr; 14(2):149-54.
    View in: PubMed
    Score: 0.008
  132. Guanine nucleotide binding proteins in opioid-dependent patients. Biol Psychiatry. 1997 Jan 15; 41(2):130-4.
    View in: PubMed
    Score: 0.008
  133. Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: a pilot study. J Neuropsychiatry Clin Neurosci. 1997; 9(1):29-36.
    View in: PubMed
    Score: 0.008
  134. Acute cocaine effects on absolute cerebral blood flow. Psychopharmacology (Berl). 1996 Nov; 128(1):17-20.
    View in: PubMed
    Score: 0.007
  135. The a-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals. Pharmacogenet Genomics. 2016 09; 26(9):428-35.
    View in: PubMed
    Score: 0.007
  136. Abstinence symptomatology associated with cessation of chronic cocaine abuse among methadone-maintained patients. Am J Drug Alcohol Abuse. 1996 Aug; 22(3):377-88.
    View in: PubMed
    Score: 0.007
  137. Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study. Int J Neuropsychopharmacol. 2016 07; 19(7).
    View in: PubMed
    Score: 0.007
  138. A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal. Eur J Pharmacol. 1996 Jul 04; 307(3):251-7.
    View in: PubMed
    Score: 0.007
  139. Pemoline for the treatment of cocaine dependence in methadone-maintained patients. J Psychoactive Drugs. 1996 Jul-Sep; 28(3):301-4.
    View in: PubMed
    Score: 0.007
  140. Smoking and Serum Lipid Profiles in Schizophrenia. Neurosci Bull. 2016 Aug; 32(4):383-8.
    View in: PubMed
    Score: 0.007
  141. Contribution of IL-10 and its -592 A/C polymorphism to cognitive functions in first-episode drug-naive schizophrenia. Brain Behav Immun. 2016 Oct; 57:116-124.
    View in: PubMed
    Score: 0.007
  142. Serum IL-18 level, clinical symptoms and IL-18-607A/C polymorphism among chronic patients with schizophrenia in a Chinese Han population. Psychoneuroendocrinology. 2016 06; 68:140-7.
    View in: PubMed
    Score: 0.007
  143. Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal. J Pharmacol Exp Ther. 1996 Mar; 276(3):1128-35.
    View in: PubMed
    Score: 0.007
  144. The effect of gamma-hydroxybutyric acid on naloxone-precipitated opiate withdrawal. Neuropsychopharmacology. 1996 Mar; 14(3):187-93.
    View in: PubMed
    Score: 0.007
  145. Extensive white matter abnormalities and clinical symptoms in drug-naive patients with first-episode schizophrenia: a voxel-based diffusion tensor imaging study. J Clin Psychiatry. 2016 Feb; 77(2):205-11.
    View in: PubMed
    Score: 0.007
  146. Gender differences in response to intranasal cocaine administration to humans. Biol Psychiatry. 1996 Jan 15; 39(2):147-8.
    View in: PubMed
    Score: 0.007
  147. Operationalizing NIMH Research Domain Criteria (RDoC) in naturalistic clinical settings. Bull Menninger Clin. 2016; 80(3):187-212.
    View in: PubMed
    Score: 0.007
  148. Reliability of sequential naloxone challenge tests. Am J Drug Alcohol Abuse. 1995 Nov; 21(4):453-67.
    View in: PubMed
    Score: 0.007
  149. Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients. Am J Drug Alcohol Abuse. 1995 Nov; 21(4):469-81.
    View in: PubMed
    Score: 0.007
  150. Interaction of BDNF with cytokines in chronic schizophrenia. Brain Behav Immun. 2016 Jan; 51:169-175.
    View in: PubMed
    Score: 0.007
  151. Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders. Pharmacogenet Genomics. 2015 Jun; 25(6):296-304.
    View in: PubMed
    Score: 0.007
  152. Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans. Biol Psychiatry. 1995 Apr 15; 37(8):560-3.
    View in: PubMed
    Score: 0.007
  153. Inhibitory behavioral control: A stochastic dynamic causal modeling study comparing cocaine dependent subjects and controls. Neuroimage Clin. 2015; 7:837-47.
    View in: PubMed
    Score: 0.007
  154. Effects of ethnicity on low-dose opiate stabilization. J Subst Abuse Treat. 1995 Mar-Apr; 12(2):111-6.
    View in: PubMed
    Score: 0.007
  155. ZNF804A variants confer risk for heroin addiction and affect decision making and gray matter volume in heroin abusers. Addict Biol. 2016 May; 21(3):657-66.
    View in: PubMed
    Score: 0.007
  156. Reinforcement sensitivity underlying treatment-seeking smokers' affect, smoking reinforcement motives, and affective responses. Psychol Addict Behav. 2015 Jun; 29(2):300-311.
    View in: PubMed
    Score: 0.007
  157. A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of JDTic. Neuropsychopharmacology. 2015 Aug; 40(9):2059-65.
    View in: PubMed
    Score: 0.007
  158. A single-blind investigation of four auricular needle puncture configurations. Am J Chin Med. 1995; 23(2):105-14.
    View in: PubMed
    Score: 0.007
  159. Withdrawal Symptoms and Nicotine Dependence Severity Predict Virtual Reality Craving in Cigarette-Deprived Smokers. Nicotine Tob Res. 2015 Jul; 17(7):796-802.
    View in: PubMed
    Score: 0.006
  160. Inhibitory behavioral control: a stochastic dynamic causal modeling study using network discovery analysis. Brain Connect. 2015 Apr; 5(3):177-86.
    View in: PubMed
    Score: 0.006
  161. Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance. Am J Drug Alcohol Abuse. 1994 Nov; 20(4):445-58.
    View in: PubMed
    Score: 0.006
  162. Cue-elicited cocaine craving and autogenic relaxation. Association with treatment outcome. J Subst Abuse Treat. 1994 Nov-Dec; 11(6):549-52.
    View in: PubMed
    Score: 0.006
  163. HIV infection and cocaine use in methadone maintained and untreated intravenous drug users. Drug Alcohol Depend. 1994 Oct; 36(2):109-13.
    View in: PubMed
    Score: 0.006
  164. The influence of dopamine ?-hydroxylase gene polymorphism rs1611115 on levodopa/carbidopa treatment for cocaine dependence: a preliminary study. Pharmacogenet Genomics. 2014 Jul; 24(7):370-3.
    View in: PubMed
    Score: 0.006
  165. Buprenorphine: duration of blockade of effects of intramuscular hydromorphone. Drug Alcohol Depend. 1994 Apr; 35(2):141-9.
    View in: PubMed
    Score: 0.006
  166. Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms. J Clin Psychopharmacol. 2014 Apr; 34(2):234-9.
    View in: PubMed
    Score: 0.006
  167. The interaction of polymorphisms of IL10 and DBH was associated with general symptoms of PANSS with TD in Chinese Han schizophrenic patients. PLoS One. 2013; 8(8):e70963.
    View in: PubMed
    Score: 0.006
  168. Association of BDNF gene polymorphisms with schizophrenia and clinical symptoms in a Chinese population. Am J Med Genet B Neuropsychiatr Genet. 2013 Sep; 162B(6):538-45.
    View in: PubMed
    Score: 0.006
  169. Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans. Biol Psychiatry. 1993 Jul 1-15; 34(1-2):66-74.
    View in: PubMed
    Score: 0.006
  170. ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse. Pharmacogenet Genomics. 2013 Jul; 23(7):333-40.
    View in: PubMed
    Score: 0.006
  171. Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 01; 46:71-7.
    View in: PubMed
    Score: 0.006
  172. Buprenorphine versus methadone maintenance for opioid dependence. J Nerv Ment Dis. 1993 Jun; 181(6):358-64.
    View in: PubMed
    Score: 0.006
  173. Association between DBH 19 bp insertion/deletion polymorphism and cognition in first-episode schizophrenic patients. Schizophr Res. 2013 Jul; 147(2-3):236-40.
    View in: PubMed
    Score: 0.006
  174. Association of the dopamine ?-hydroxylase 19 bp insertion/deletion polymorphism with positive symptoms but not tardive dyskinesia in schizophrenia. Hum Psychopharmacol. 2013 May; 28(3):230-7.
    View in: PubMed
    Score: 0.006
  175. The type 2 diabetes mellitus susceptibility gene IGF2BP2 is associated with schizophrenia in a Han Chinese population. J Clin Psychiatry. 2013 Apr; 74(4):e287-92.
    View in: PubMed
    Score: 0.006
  176. Serotonin transporter genotype and mild traumatic brain injury independently influence resilience and perception of limitations in veterans. J Psychiatr Res. 2013 Jun; 47(6):835-42.
    View in: PubMed
    Score: 0.006
  177. Spirituality and confidence to resist substance use among celebrate recovery participants. J Relig Health. 2013 Mar; 52(1):107-13.
    View in: PubMed
    Score: 0.006
  178. Gender differences in cocaine use and treatment response. J Subst Abuse Treat. 1993 Jan-Feb; 10(1):63-6.
    View in: PubMed
    Score: 0.006
  179. Low BDNF is associated with cognitive deficits in patients with type 2 diabetes. Psychopharmacology (Berl). 2013 May; 227(1):93-100.
    View in: PubMed
    Score: 0.006
  180. Gender differences in socio-demographic and clinical characteristics of methamphetamine inpatients in a Chinese population. Drug Alcohol Depend. 2013 Jun 01; 130(1-3):94-100.
    View in: PubMed
    Score: 0.006
  181. The impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial. PLoS One. 2012; 7(11):e47702.
    View in: PubMed
    Score: 0.006
  182. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. Arch Gen Psychiatry. 1992 Nov; 49(11):894-8.
    View in: PubMed
    Score: 0.006
  183. Alpha oscillations in response to affective and cigarette-related stimuli in smokers. Nicotine Tob Res. 2013 May; 15(5):917-24.
    View in: PubMed
    Score: 0.006
  184. Beta endorphin levels during heroin, methadone, buprenorphine, and naloxone challenges: preliminary findings. Biol Psychiatry. 1992 Sep 15; 32(6):523-8.
    View in: PubMed
    Score: 0.006
  185. No association between the type 2 diabetes mellitus susceptibility gene, SLC30A8 and schizophrenia in a Chinese population. Hum Psychopharmacol. 2012 Jul; 27(4):392-6.
    View in: PubMed
    Score: 0.005
  186. Association of functional COMT Val108/Met polymorphism with smoking cessation in a nicotine replacement therapy. J Neural Transm (Vienna). 2012 Dec; 119(12):1491-8.
    View in: PubMed
    Score: 0.005
  187. Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology. J Psychiatr Res. 2012 Aug; 46(8):1093-8.
    View in: PubMed
    Score: 0.005
  188. The dopamine b-hydroxylase 19 bp insertion/deletion polymorphism was associated with first-episode but not medicated chronic schizophrenia. J Psychiatr Res. 2012 Jun; 46(6):733-7.
    View in: PubMed
    Score: 0.005
  189. Association of catechol-O-methyltransferase gene polymorphisms with schizophrenia and negative symptoms in a Chinese population. Am J Med Genet B Neuropsychiatr Genet. 2012 Jun; 159B(4):370-5.
    View in: PubMed
    Score: 0.005
  190. Differential cigarette-related startle cue reactivity among light, moderate, and heavy smokers. Addict Behav. 2012 Aug; 37(8):885-9.
    View in: PubMed
    Score: 0.005
  191. Noradrenergic a1 receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial. PLoS One. 2012; 7(2):e30854.
    View in: PubMed
    Score: 0.005
  192. Treatment of dual diagnosis patients: a relapse prevention group approach. J Subst Abuse Treat. 1992; 9(4):305-9.
    View in: PubMed
    Score: 0.005
  193. Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone. NIDA Res Monogr. 1992; 121:101-19.
    View in: PubMed
    Score: 0.005
  194. Improving treatment outcome in pregnant opiate-dependent women. J Subst Abuse Treat. 1992; 9(4):327-30.
    View in: PubMed
    Score: 0.005
  195. The predictive validity of the dependence syndrome in opiate abusers. Am J Drug Alcohol Abuse. 1992; 18(2):145-56.
    View in: PubMed
    Score: 0.005
  196. Association between TNF-a promoter -308A/G polymorphism and tardive dyskinesian Chinese Han patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Apr 27; 37(1):106-10.
    View in: PubMed
    Score: 0.005
  197. Alcoholism and depressive disorders in opioid addicts and their family members. Compr Psychiatry. 1991 Nov-Dec; 32(6):521-7.
    View in: PubMed
    Score: 0.005
  198. Pharmacotherapy improves treatment outcome in depressed cocaine addicts. J Psychoactive Drugs. 1991 Oct-Dec; 23(4):417-25.
    View in: PubMed
    Score: 0.005
  199. The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine. Hum Psychopharmacol. 2011 Aug; 26(6):392-6.
    View in: PubMed
    Score: 0.005
  200. Gender differences in the specificity of alcoholism transmission among the relatives of opioid addicts. J Nerv Ment Dis. 1991 Jul; 179(7):392-400.
    View in: PubMed
    Score: 0.005
  201. Treatment of heroin addicts using buprenorphine. Am J Drug Alcohol Abuse. 1991 Jun; 17(2):119-28.
    View in: PubMed
    Score: 0.005
  202. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis. 1991 Jun; 179(6):366-70.
    View in: PubMed
    Score: 0.005
  203. Reduced plasma total antioxidant status in first-episode drug-naive patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 01; 35(4):1064-7.
    View in: PubMed
    Score: 0.005
  204. Performance-based assessment of functional skills in severe mental illness: results of a large-scale study in China. J Psychiatr Res. 2011 Aug; 45(8):1089-94.
    View in: PubMed
    Score: 0.005
  205. Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical and atypical antipsychotics. Psychopharmacology (Berl). 2011 Jul; 216(1):9-16.
    View in: PubMed
    Score: 0.005
  206. Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Psychopharmacol Bull. 1991; 27(3):337-43.
    View in: PubMed
    Score: 0.005
  207. SPECT regional cerebral blood flow and neuropsychological testing in non-demented HIV-positive drug abusers: preliminary results. Prog Neuropsychopharmacol Biol Psychiatry. 1991; 15(5):649-62.
    View in: PubMed
    Score: 0.005
  208. Association between the 5-HTR1B gene polymorphisms and alcohol dependence in a Han Chinese population. Brain Res. 2011 Feb 28; 1376:1-9.
    View in: PubMed
    Score: 0.005
  209. The dexamethasone suppression test and thyrotropin-releasing hormone stimulation test in posttraumatic stress disorder. Biol Psychiatry. 1990 Oct 15; 28(8):657-64.
    View in: PubMed
    Score: 0.005
  210. Gender differences in the prevalence of diabetes mellitus in chronic hospitalized patients with schizophrenia on long-term antipsychotics. Psychiatry Res. 2011 Apr 30; 186(2-3):451-3.
    View in: PubMed
    Score: 0.005
  211. Behavioral effects of gamma-hydroxybutyrate in humans. Behav Pharmacol. 2010 Jul; 21(4):332-42.
    View in: PubMed
    Score: 0.005
  212. The study of BDNF Val66Met polymorphism in Chinese schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16; 34(6):930-3.
    View in: PubMed
    Score: 0.005
  213. Reduced status of plasma total antioxidant capacity in schizophrenia with tardive dyskinesia. J Psychiatr Res. 2010 Nov; 44(15):1111-2.
    View in: PubMed
    Score: 0.005
  214. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is not associated with risk for schizophrenia and tardive dyskinesia in Han Chinese population. Schizophr Res. 2010 Jul; 120(1-3):240-2.
    View in: PubMed
    Score: 0.005
  215. Association of the manganese superoxide dismutase gene Ala-9Val polymorphism with clinical phenotypes and tardive dyskinesia in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30; 34(4):692-6.
    View in: PubMed
    Score: 0.005
  216. Opioid antagonist challenges in buprenorphine maintained patients. Drug Alcohol Depend. 1990 Feb; 25(1):73-8.
    View in: PubMed
    Score: 0.005
  217. Mazindol treatment of cocaine abuse. A double-blind investigation. NIDA Res Monogr. 1990; 105:514.
    View in: PubMed
    Score: 0.005
  218. Cocaine symptoms are predicted by familial psychopathology. NIDA Res Monogr. 1990; 105:603-4.
    View in: PubMed
    Score: 0.005
  219. Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuse. Am J Drug Alcohol Abuse. 1990; 16(3-4):329-36.
    View in: PubMed
    Score: 0.005
  220. Depressive symptoms during buprenorphine treatment of opioid abusers. J Subst Abuse Treat. 1990; 7(1):51-4.
    View in: PubMed
    Score: 0.005
  221. Stress enhances retrieval of drug-related memories in abstinent heroin addicts. Neuropsychopharmacology. 2010 Feb; 35(3):720-6.
    View in: PubMed
    Score: 0.005
  222. Decreased levels of serum brain-derived neurotrophic factor in drug-na?ve first-episode schizophrenia: relationship to clinical phenotypes. Psychopharmacology (Berl). 2009 Dec; 207(3):375-80.
    View in: PubMed
    Score: 0.005
  223. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13; 33(8):1508-12.
    View in: PubMed
    Score: 0.005
  224. Cocaine abuse and opioid withdrawal. Lancet. 1989 Jul 15; 2(8655):165-6.
    View in: PubMed
    Score: 0.004
  225. Association between monoamine oxidase (MAO)-A gene variants and schizophrenia in a Chinese population. Brain Res. 2009 Sep 01; 1287:67-73.
    View in: PubMed
    Score: 0.004
  226. Effect of rapamycin on cue-induced drug craving in abstinent heroin addicts. Eur J Pharmacol. 2009 Aug 01; 615(1-3):108-12.
    View in: PubMed
    Score: 0.004
  227. Circadian alteration in neurobiology during 30 days of abstinence in heroin users. Biol Psychiatry. 2009 May 15; 65(10):905-12.
    View in: PubMed
    Score: 0.004
  228. Inpatient vs. outpatient cocaine abuse treatments. NIDA Res Monogr. 1989; 95:312-3.
    View in: PubMed
    Score: 0.004
  229. Severity of precipitated opiate withdrawal predicts drug dependence by DSM-III-R criteria. Am J Drug Alcohol Abuse. 1989; 15(3):237-50.
    View in: PubMed
    Score: 0.004
  230. Personality disorders in opiate addicts show prognostic specificity. J Subst Abuse Treat. 1989; 6(3):163-8.
    View in: PubMed
    Score: 0.004
  231. Serum thyroxine change and clinical recovery in psychiatric inpatients. Biol Psychiatry. 1989 Jan; 25(1):67-74.
    View in: PubMed
    Score: 0.004
  232. Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci. 1989; 44(13):887-92.
    View in: PubMed
    Score: 0.004
  233. Family support and employment as predictors of smoking cessation success: a randomized, double-blind, placebo-controlled trial of nicotine sublingual tablets in chinese smokers. Am J Drug Alcohol Abuse. 2009; 35(3):183-8.
    View in: PubMed
    Score: 0.004
  234. Time-dependent neuroendocrine alterations and drug craving during the first month of abstinence in heroin addicts. Am J Drug Alcohol Abuse. 2009; 35(5):267-72.
    View in: PubMed
    Score: 0.004
  235. Altered interleukin-3 serum levels in drug-na?ve and neuroleptic-treated schizophrenic patients. Schizophr Res. 2008 Dec; 106(2-3):369-70.
    View in: PubMed
    Score: 0.004
  236. Diurnal variation in cue-induced responses among protracted abstinent heroin users. Pharmacol Biochem Behav. 2009 Jan; 91(3):468-72.
    View in: PubMed
    Score: 0.004
  237. Preliminary study of buprenorphine and bupropion for opioid-dependent smokers. Am J Addict. 2008 Jul-Aug; 17(4):287-92.
    View in: PubMed
    Score: 0.004
  238. The CCR5 32-bp deletion allele is rare in a Chinese population. Schizophr Res. 2008 Apr; 101(1-3):341-3.
    View in: PubMed
    Score: 0.004
  239. Antecedents and consequences of cocaine abuse among opioid addicts. A 2.5-year follow-up. J Nerv Ment Dis. 1988 Mar; 176(3):176-81.
    View in: PubMed
    Score: 0.004
  240. Serum testosterone differences between patients with schizophrenia and those with affective disorder. Biol Psychiatry. 1988 Feb 15; 23(4):357-66.
    View in: PubMed
    Score: 0.004
  241. Differential diagnosis of psychiatric comorbidity in substance abusers. J Subst Abuse Treat. 1988; 5(4):201-6.
    View in: PubMed
    Score: 0.004
  242. Buprenorphine detoxification from opioid dependence: a pilot study. Life Sci. 1988; 42(6):635-41.
    View in: PubMed
    Score: 0.004
  243. Serum cortisol secretion during heroin abstinence is elevated only nocturnally. Am J Drug Alcohol Abuse. 2008; 34(3):321-8.
    View in: PubMed
    Score: 0.004
  244. Substance-use disorders in DSM-III-R. Evidence for the dependence syndrome across different psychoactive substances. Br J Psychiatry. 1987 Dec; 151:834-43.
    View in: PubMed
    Score: 0.004
  245. A preliminary study of desipramine in the treatment of cocaine abuse in methadone maintenance patients. J Clin Psychiatry. 1987 Nov; 48(11):442-4.
    View in: PubMed
    Score: 0.004
  246. Beta endorphin levels in CSF during methadone maintenance. Life Sci. 1987 Aug 31; 41(9):1071-6.
    View in: PubMed
    Score: 0.004
  247. Clinical efficacy of citalopram alone or augmented with bupropion in methadone-stabilized patients. Am J Addict. 2007 May-Jun; 16(3):187-94.
    View in: PubMed
    Score: 0.004
  248. A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped? Arch Gen Psychiatry. 1987 Mar; 44(3):281-4.
    View in: PubMed
    Score: 0.004
  249. Association of functional catechol O-methyl transferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers. Psychopharmacology (Berl). 2007 Mar; 190(4):449-56.
    View in: PubMed
    Score: 0.004
  250. Source of income as a predictor in opioid addicts: 2.5 year follow-up. NIDA Res Monogr. 1987; 76:196-9.
    View in: PubMed
    Score: 0.004
  251. The dependence syndrome across different psychoactive substances: revised DSM-III. NIDA Res Monogr. 1987; 76:255-8.
    View in: PubMed
    Score: 0.004
  252. Predictors of 2.5-year outcome in opioid addicts: pretreatment source of income. Am J Drug Alcohol Abuse. 1987; 13(1-2):19-32.
    View in: PubMed
    Score: 0.004
  253. Relationship of marital structure and interactions to opiate abuse relapse. Am J Drug Alcohol Abuse. 1987; 13(4):387-99.
    View in: PubMed
    Score: 0.004
  254. Multidimensionality and prediction of treatment outcome in opioid addicts: 2.5-year follow-up. Compr Psychiatry. 1987 Jan-Feb; 28(1):3-13.
    View in: PubMed
    Score: 0.004
  255. Treatment of severe lithium-induced polyuria with amiloride. Am J Psychiatry. 1986 Dec; 143(12):1563-8.
    View in: PubMed
    Score: 0.004
  256. Psychopathology in opioid addicts. Psychiatr Clin North Am. 1986 Sep; 9(3):515-32.
    View in: PubMed
    Score: 0.004
  257. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug Alcohol Depend. 2007 Feb 23; 87(1):1-9.
    View in: PubMed
    Score: 0.004
  258. A preliminary study of beta endorphin during chronic naltrexone maintenance treatment in ex-opiate addicts. Life Sci. 1986 Jul 07; 39(1):55-9.
    View in: PubMed
    Score: 0.004
  259. Antisocial personality and stress-induced brain activation in cocaine-dependent patients. Neuroreport. 2006 Feb 27; 17(3):243-7.
    View in: PubMed
    Score: 0.004
  260. Cortisol levels during chronic naltrexone maintenance treatment in ex-opiate addicts. Biol Psychiatry. 1986 Feb; 21(2):217-20.
    View in: PubMed
    Score: 0.004
  261. Abuse of cocaine with opioids: psychological aspects of treatment. NIDA Res Monogr. 1986; 67:278-82.
    View in: PubMed
    Score: 0.003
  262. The effect of multiple family therapy on addict family functioning: a pilot study. Adv Alcohol Subst Abuse. 1986; 5(3):51-62.
    View in: PubMed
    Score: 0.003
  263. Cocaine abuse among opioid addicts: demographic and diagnostic factors in treatment. Am J Drug Alcohol Abuse. 1986; 12(1-2):1-16.
    View in: PubMed
    Score: 0.003
  264. A 2.5 year follow-up of treatment retention and reentry among opioid addicts. J Subst Abuse Treat. 1986; 3(3):181-9.
    View in: PubMed
    Score: 0.003
  265. Neural activity associated with stress-induced cocaine craving: a functional magnetic resonance imaging study. Psychopharmacology (Berl). 2005 Dec; 183(2):171-80.
    View in: PubMed
    Score: 0.003
  266. Parental alcoholism in opioid addicts. J Nerv Ment Dis. 1985 Aug; 173(8):461-9.
    View in: PubMed
    Score: 0.003
  267. Ethnic and gender differences among opiate addicts. Int J Addict. 1985 Aug; 20(8):1143-62.
    View in: PubMed
    Score: 0.003
  268. Sex differences in brain activation during stress imagery in abstinent cocaine users: a functional magnetic resonance imaging study. Biol Psychiatry. 2005 Mar 01; 57(5):487-94.
    View in: PubMed
    Score: 0.003
  269. Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts. Am J Drug Alcohol Abuse. 1985; 11(1-2):1-10.
    View in: PubMed
    Score: 0.003
  270. Relationship of depression to clonidine detoxification of opiate addicts. Compr Psychiatry. 1984 Sep-Oct; 25(5):503-8.
    View in: PubMed
    Score: 0.003
  271. Isradipine and dextromethorphan in methadone-maintained humans under a naloxone discrimination procedure. Eur J Pharmacol. 2004 May 03; 491(2-3):157-68.
    View in: PubMed
    Score: 0.003
  272. Perceived marital and family environment of opiate addicts. Am J Drug Alcohol Abuse. 1984; 10(4):491-501.
    View in: PubMed
    Score: 0.003
  273. The relationship of the Maudsley Personality Inventory to depression in addicts. Compr Psychiatry. 1983 Nov-Dec; 24(6):535-42.
    View in: PubMed
    Score: 0.003
  274. Family denial as a prognostic factor in opiate addict treatment outcome. J Nerv Ment Dis. 1983 Oct; 171(10):611-6.
    View in: PubMed
    Score: 0.003
  275. Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans. Pharmacol Biochem Behav. 2003 Jul; 75(4):801-8.
    View in: PubMed
    Score: 0.003
  276. Relationship of depression to psychosocial stressors in heroin addicts. J Nerv Ment Dis. 1983 Feb; 171(2):97-104.
    View in: PubMed
    Score: 0.003
  277. DSM-III personality disorders in opiate addicts. Compr Psychiatry. 1982 Nov-Dec; 23(6):572-81.
    View in: PubMed
    Score: 0.003
  278. Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biol Psychiatry. 2002 Apr 15; 51(8):642-51.
    View in: PubMed
    Score: 0.003
  279. Complementary marital roles of male heroin addicts: evolution and intervention tactics. Am J Drug Alcohol Abuse. 1982-1983; 9(2):155-69.
    View in: PubMed
    Score: 0.003
  280. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology. 2002 Jan; 26(1):75-85.
    View in: PubMed
    Score: 0.003
  281. Quantitative morphology of the caudate and putamen in patients with cocaine dependence. Am J Psychiatry. 2001 Mar; 158(3):486-9.
    View in: PubMed
    Score: 0.003
  282. Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine. Psychopharmacology (Berl). 2001 Mar; 154(3):274-81.
    View in: PubMed
    Score: 0.003
  283. Neuroleptic use in the treatment of Post-Traumatic Stress Disorder. Psychiatr Q. 2001; 72(3):197-213.
    View in: PubMed
    Score: 0.002
  284. Sex differences in self-reported and physiological response to oral cocaine and placebo in humans. Am J Drug Alcohol Abuse. 2000 Nov; 26(4):643-57.
    View in: PubMed
    Score: 0.002
  285. Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry. 2000 Oct; 157(10):1700-3.
    View in: PubMed
    Score: 0.002
  286. Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients. Am J Psychiatry. 2000 Jul; 157(7):1134-40.
    View in: PubMed
    Score: 0.002
  287. Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial. Biol Psychiatry. 2000 Jun 15; 47(12):1080-6.
    View in: PubMed
    Score: 0.002
  288. Individual differences in humans responding under a cocaine discrimination procedure: discriminators versus nondiscriminators. Exp Clin Psychopharmacol. 1999 Nov; 7(4):391-8.
    View in: PubMed
    Score: 0.002
  289. The effects of naltrexone maintenance on the response to yohimbine in healthy volunteers. Biol Psychiatry. 1999 Jun 15; 45(12):1636-45.
    View in: PubMed
    Score: 0.002
  290. When is less treatment better? The role of social anxiety in matching methadone patients to psychosocial treatments. J Consult Clin Psychol. 1998 Dec; 66(6):924-31.
    View in: PubMed
    Score: 0.002
  291. Disulfiram effects on acute cocaine administration. Drug Alcohol Depend. 1998 Sep 01; 52(1):27-39.
    View in: PubMed
    Score: 0.002
  292. Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone--a multiple-dose study. Biol Psychiatry. 1998 Aug 15; 44(4):250-9.
    View in: PubMed
    Score: 0.002
  293. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. Am J Med. 1998 Aug; 105(2):100-5.
    View in: PubMed
    Score: 0.002
  294. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT. Am J Psychiatry. 1998 Jun; 155(6):832-4.
    View in: PubMed
    Score: 0.002
  295. [123I]beta-CIT SPECT imaging of dopamine transporter availability after mazindol administration in human cocaine addicts. Psychopharmacology (Berl). 1998 Jun; 137(4):321-5.
    View in: PubMed
    Score: 0.002
  296. Chronic disulfiram treatment effects on intranasal cocaine administration: initial results. Biol Psychiatry. 1998 Apr 01; 43(7):540-3.
    View in: PubMed
    Score: 0.002
  297. Three methods of opioid detoxification in a primary care setting. A randomized trial. Ann Intern Med. 1997 Oct 01; 127(7):526-30.
    View in: PubMed
    Score: 0.002
  298. Effect of alpha-methyl-para-tyrosine on response to cocaine challenge. Biol Psychiatry. 1997 Aug 01; 42(3):181-90.
    View in: PubMed
    Score: 0.002
  299. Decreased digital flow persists after the abatement of cocaine-induced hemodynamic stimulation. Anesth Analg. 1997 Jan; 84(1):46-50.
    View in: PubMed
    Score: 0.002
  300. A pilot study of primary-care-based buprenorphine maintenance for heroin dependence. Am J Drug Alcohol Abuse. 1996 Nov; 22(4):523-31.
    View in: PubMed
    Score: 0.002
  301. A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug Alcohol Depend. 1995 Dec; 40(2):125-31.
    View in: PubMed
    Score: 0.002
  302. Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users. J Subst Abuse Treat. 1995 Nov-Dec; 12(6):423-8.
    View in: PubMed
    Score: 0.002
  303. Mazindol treatment for cocaine dependence. Drug Alcohol Depend. 1995 Oct; 39(3):245-52.
    View in: PubMed
    Score: 0.002
  304. Acupuncture for the treatment of cocaine addiction. Investigation of a needle puncture control. J Subst Abuse Treat. 1995 May-Jun; 12(3):195-205.
    View in: PubMed
    Score: 0.002
  305. Serotonergic mechanisms of cocaine effects in humans. Psychopharmacology (Berl). 1995 May; 119(2):179-85.
    View in: PubMed
    Score: 0.002
  306. Tryptophan depletion and attenuation of cue-induced craving for cocaine. Am J Psychiatry. 1995 May; 152(5):778-83.
    View in: PubMed
    Score: 0.002
  307. Differences between responders and nonresponders to cocaine cues in the laboratory. Addict Behav. 1995 Mar-Apr; 20(2):215-24.
    View in: PubMed
    Score: 0.002
  308. Opiate dependence and withdrawal: preliminary assessment using single photon emission computerized tomography (SPECT). Am J Drug Alcohol Abuse. 1995 Feb; 21(1):47-63.
    View in: PubMed
    Score: 0.002
  309. Noradrenergic dysregulation during discontinuation of cocaine use in addicts. Arch Gen Psychiatry. 1994 Sep; 51(9):713-9.
    View in: PubMed
    Score: 0.002
  310. Nicotine dependence and schizophrenia. Hosp Community Psychiatry. 1994 Mar; 45(3):204-6.
    View in: PubMed
    Score: 0.002
  311. Changes concurrent with initiation of abstinence from cocaine abuse. J Subst Abuse Treat. 1993 Nov-Dec; 10(6):577-83.
    View in: PubMed
    Score: 0.002
  312. Alprazolam and benzodiazepine dependence. J Clin Psychiatry. 1993 Oct; 54 Suppl:64-75; discussion 76-7.
    View in: PubMed
    Score: 0.001
  313. Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology (Berl). 1993; 111(1):39-46.
    View in: PubMed
    Score: 0.001
  314. Dopaminergic responsivity during cocaine abstinence: a pilot study. Psychiatry Res. 1992 Jul; 43(1):77-85.
    View in: PubMed
    Score: 0.001
  315. Baclofen-assisted detoxification from opiates. A pilot study. J Subst Abuse Treat. 1992; 9(2):139-42.
    View in: PubMed
    Score: 0.001
  316. Multidimensional hormonal discrimination of paranoid schizophrenic from bipolar manic patients. Biol Psychiatry. 1991 Mar 01; 29(5):457-66.
    View in: PubMed
    Score: 0.001
  317. Psychiatric disorders in relatives of probands with opiate addiction. Arch Gen Psychiatry. 1991 Jan; 48(1):33-42.
    View in: PubMed
    Score: 0.001
  318. Serum thyroxine levels in schizophrenic and affective disorder diagnostic subgroups. J Nerv Ment Dis. 1989 Jun; 177(6):351-8.
    View in: PubMed
    Score: 0.001
  319. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry. 1989 Feb; 46(2):117-21.
    View in: PubMed
    Score: 0.001
  320. A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. Am J Psychiatry. 1988 Oct; 145(10):1289-91.
    View in: PubMed
    Score: 0.001
  321. Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. Br J Addict. 1988 May; 83(5):567-75.
    View in: PubMed
    Score: 0.001
  322. A field trial of DSM-III-R psychoactive substance dependence disorders. Am J Psychiatry. 1987 Mar; 144(3):351-5.
    View in: PubMed
    Score: 0.001
  323. The antecedents and benefits of achieving abstinence in opioid addicts: a 2.5-year follow-up study. Am J Drug Alcohol Abuse. 1987; 13(3):213-29.
    View in: PubMed
    Score: 0.001
  324. Long-term changes in current psychiatric diagnoses of treated opiate addicts. Compr Psychiatry. 1986 Sep-Oct; 27(5):480-98.
    View in: PubMed
    Score: 0.001
  325. Nontolerance to the opioid antagonism of naltrexone. Biol Psychiatry. 1985 Jan; 20(1):66-72.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.